Back
Cadrenal Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
42
CVKD
Cadrenal Therapeutics
Last Price:
0.47
Seasonality Move:
-48.05%
Sell
19
NBY
NovaBay Pharmaceuticals
Last Price:
2.12
Seasonality Move:
-12.93%
Sell
42
Cadrenal Therapeutics (CVKD)
is a Sell
Is Cadrenal Therapeutics a Buy, Sell or Hold?
- The current Cadrenal Therapeutics [CVKD] share price is $0.47. The Score for CVKD is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CVKD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $2.10. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CVKD Stock Price Chart
What is Cadrenal Therapeutics's stock price today?
-
The Cadrenal Therapeutics share price today is $0.47
The current trend is relatively stagnant and CVKD is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $2.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
CVKD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 50.91 | Buy |
| Chaikin Money Flow: | 8878 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.43 - 0.49) | Buy |
| Bollinger Bands (100): | (0.37 - 0.81) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 35.81 | Sell |
| Chaikin Money Flow: | -120877 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.21 - 4.55) | Sell |
| Bollinger Bands (100): | (2.85 - 5.07) | Sell |
CVKD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.47 | Sell |
| 20-day SMA: | 0.46 | Buy |
| 50-day SMA: | 0.45 | Buy |
| 200-day SMA: | 0.62 | Sell |
| 8-day EMA: | 0.47 | Sell |
| 20-day EMA: | 0.46 | Buy |
| 50-day EMA: | 0.48 | Sell |
| 200-day EMA: | 0.73 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.33 | Sell |
| 20-day SMA: | 2.97 | Sell |
| 50-day SMA: | 3.21 | Sell |
| 200-day SMA: | 7.59 | Sell |
| 8-day EMA: | 2.34 | Sell |
| 20-day EMA: | 2.79 | Sell |
| 50-day EMA: | 3.33 | Sell |
| 200-day EMA: | 14.4 | Sell |
Cadrenal Therapeutics Earnings Growth & CVKD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.04 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.48 per share, an increase next quarter of $0.35 per share, an increase this year of $74.90 per share, and an increase next year of $5.60 per share.
Cadrenal Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||